Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
SEQanswers sponsors/vendors can post commercial content here with approval from admin. Please support our sponsors!
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by SoftGenetics, 09-02-2009, 12:10 PM
|
0 responses
3,204 views
0 likes
|
Last Post
by SoftGenetics
09-02-2009, 12:10 PM
|
||
Started by SoftGenetics, 08-25-2009, 06:14 AM
|
0 responses
3,173 views
0 likes
|
Last Post
by SoftGenetics
08-25-2009, 06:14 AM
|
||
Started by GenomeQuest, 07-30-2009, 07:07 AM
|
4 responses
3,222 views
0 likes
|
Last Post
by GenomeQuest
08-18-2009, 07:23 AM
|
||
Started by geschickten, 07-30-2009, 08:39 PM
|
3 responses
4,041 views
0 likes
|
Last Post
by ECO
07-30-2009, 09:23 PM
|
||
Started by SoftGenetics, 06-22-2009, 07:01 AM
|
0 responses
3,178 views
0 likes
|
Last Post
by SoftGenetics
06-22-2009, 07:01 AM
|
||
Started by Genomatix, 04-21-2009, 11:34 AM
|
0 responses
3,291 views
0 likes
|
Last Post
by Genomatix
04-21-2009, 11:34 AM
|
||
Started by Genomatix, 04-09-2009, 12:12 PM
|
0 responses
3,008 views
0 likes
|
Last Post
by Genomatix
04-09-2009, 12:12 PM
|
||
Started by Genomatix, 03-20-2009, 07:49 AM
|
3 responses
3,654 views
0 likes
|
Last Post
by Genomatix
04-09-2009, 12:07 PM
|
||
Started by PNG, 03-31-2009, 07:53 AM
|
0 responses
2,850 views
0 likes
|
Last Post
by PNG
03-31-2009, 07:53 AM
|
No topics found.
-
Page of 0
-
Filter
Webinars
Collapse
-
by seqadminGenomics technologies have significantly enhanced our comprehension of the complex immune system. Our upcoming webinar explores innovative applications...
-
Channel: Webinar Series
05-01-2024, 06:50 AM -
-
by seqadminJoin us for our insightful SEQanswers webinar "Harnessing NGS in Cancer Research." This session will feature a panel of scientists discussing...
-
Channel: Webinar Series
03-18-2024, 08:22 AM -
Recent Articles
Collapse
-
by seqadmin
The field of epigenetics has traditionally concentrated more on DNA and how changes like methylation and phosphorylation of histones impact gene expression and regulation. However, our increased understanding of RNA modifications and their importance in cellular processes has led to a rise in epitranscriptomics research. “Epitranscriptomics brings together the concepts of epigenetics and gene expression,” explained Adrien Leger, PhD, Principal Research Scientist...-
Channel: Articles
04-22-2024, 07:01 AM -
-
by seqadmin
Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...-
Channel: Articles
04-04-2024, 04:25 PM -
-
by seqadmin
Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...-
Channel: Articles
03-22-2024, 06:39 AM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, 05-02-2024, 08:06 AM
|
0 responses
16 views
0 likes
|
Last Post
by seqadmin
05-02-2024, 08:06 AM
|
||
Started by seqadmin, 04-30-2024, 12:17 PM
|
0 responses
19 views
0 likes
|
Last Post
by seqadmin
04-30-2024, 12:17 PM
|
||
Started by seqadmin, 04-29-2024, 10:49 AM
|
0 responses
24 views
0 likes
|
Last Post
by seqadmin
04-29-2024, 10:49 AM
|